Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
253.00    -7.00 (-2.69%)
Bid:
253.00
Ask:
262.00
Spread: 9.00 (3.557%)
Market Cap: £226.58m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Interim Management Statement

16 May 2013 07:00

RNS Number : 8281E
Wilmington Group Plc
16 May 2013
 



16 May 2013

 

Wilmington Group plc

 

Interim Management Statement

 

 

Wilmington Group, the provider of Information, Compliance, and Education to professional markets presents its Interim Management Statement for the period from 1 January 2013 to the date of this statement incorporating the Group's third quarter trading period to 31 March 2013.

 

 

Trading Review

 

The trading environment remains as reported in our interim results statement on 26 February 2013. As expected, revenue during the period from 1 January 2013 to the end of April 2013 is in line with the same four month period last year. Revenue from disposed businesses and discontinued marginal events has been offset by organic growth from our core businesses and revenues from acquired businesses. We have continued to see good growth in operating profits and improved operating margins across all the business divisions except, as previously reported, Business Intelligence which is impacted inter alia by the exiting of contract directory publishing.

 

The Group's third quarter trading was satisfactory, in line with the Board's expectations, with the continued emphasis on investing in and developing growth areas whilst removing underperforming marginal events. Across the divisions we have seen a continuation of the trading patterns reported at the interims.

 

Our higher margin Banking & Compliance, Pensions & Insurance businesses remain resilient with good renewals and revenue growth. On 1 March 2013, the Pensions & Insurance Division acquired the leading Spanish insurance market information business; Inese. The integration has gone well and March saw a successful contribution from the Inese flagship event; Insurance week.

Within the Healthcare division, reductions in sales of low margin UK mailing services and continued signs of uncertainty over recent NHS changes are affecting sales at the margin. This was offset by growth from its French medical news agency business. On 5 February 2013, the division acquired NHiS, a highly complementary provider of business intelligence on the UK healthcare market. NHiS has been integrated into the Group's systems and collaborative activities with other Wilmington Group companies have commenced.

 

As previously indicated, Business Intelligence's revenue has been adversely affected by the impact of exiting contract publishing.

 

The Accountancy division had a successful March trading month; its biggest and most important period, helped by demand surrounding the UK Government's annual fiscal budget.

 

As planned, the Legal Division revenue has been trimmed through a combination of removal of marginal events and the impact of the disposal of our Companies Formation business in June 2012.

 

Cash flow is strong and debt is reducing according to plan. During the period we utilised part of our £65m debt facility to acquire two businesses; NHiS in February and Inese in March 2013 for a net £5.0m and €1.4m respectively. As at the end of April 2013 our net debt was £37.6m (April 2012 £39.3m).

 

Outlook

 

The outlook for the full financial year remains unchanged and in line with the Board's expectations. Whilst economic conditions remain challenging, the majority of our businesses have been resilient and our internationally focussed divisions are still generating good growth. This growth, alongside contributions from our two recent acquisitions, and cost savings from initiatives already implemented, will help us achieve our full year expectations.

 

 

-End-

 

 

 

For further information, please contact:

 

Wilmington Group Plc

Charles Brady, Chief Executive

Tony Foye, Finance Director

 

FTI Consulting

Charles Palmer 

 

020 7422 6800

 

 

 

020 7831 3113

 

 

Notes to Editors

 

Wilmington Group plc is one of the UK's leading providers of Information, Compliance and Education for professional business markets. The Group provides business intelligence, information, training, education, events and support services for a variety of markets including the accountancy, banking, charities, financial services, healthcare, insurance, legal, and pensions sectors. Capitalised at approximately £135 million, Wilmington floated on the London Stock Exchange in 1995.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUUWAUPWGQA
Date   Source Headline
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20254:39 pmRNSDirector/PDMR Shareholding
3rd Mar 20254:35 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSShare repurchase programme
17th Feb 20257:00 amRNSHalf-year Report
17th Jan 20259:42 amRNSNotice of Half Year Results
4th Dec 20247:00 amRNSDirector/PDMR Shareholding
28th Nov 202411:03 amRNSResult of AGM
25th Nov 20241:37 pmRNSHolding(s) in Company
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
8th Nov 20243:13 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights
25th Oct 20247:00 amRNSAcquisition of Phoenix Health & Safety
21st Oct 20241:47 pmRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSIssue of Ordinary Shares
1st Oct 20247:00 amRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNSFinancial results for the year ended 30 June 2024
2nd Sep 20247:00 amRNSTotal Voting Rights
29th Jul 20248:59 amRNSDirector Declaration
24th Jul 20247:00 amRNSTrading Statement
10th Jul 202410:57 amRNSHolding(s) in Company
2nd Jul 20242:51 pmRNSTotal Voting Rights - Replacement
1st Jul 20247:00 amRNSTotal Voting Rights
27th Jun 20247:00 amRNSUK Healthcare Business sold for £26.3 million
26th Apr 20247:46 amRNSAPM sold for EUR 26 million
23rd Apr 20243:49 pmRNSSAYE and Director/PDMR Shareholding
19th Feb 20247:00 amRNSHalf-year Report
6th Feb 202411:12 amRNSBoard Changes
1st Feb 20247:00 amRNSMiExact sold for £9.6 million
18th Jan 202411:00 amRNSNotice of Half Year Results
2nd Jan 20247:00 amRNSTotal Voting Rights
18th Dec 20232:42 pmRNSIssue of ordinary shares
11th Dec 20233:54 pmRNSIssue of Ordinary Shares
7th Dec 20232:25 pmRNSIssue of Ordinary Shares
1st Dec 202311:40 amRNSDirector/PDMR Shareholding
30th Nov 20232:53 pmRNSIssue of Ordinary Shares
23rd Nov 20239:49 amRNSAcquisition of Astutis Ltd by Wilmington plc
22nd Nov 20232:37 pmRNSResult of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
3rd Oct 20232:52 pmRNSHolding(s) in Company
2nd Oct 202311:57 amRNSDirector/PDMR Shareholding
2nd Oct 202310:19 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSIssue of Ordinary Shares
25th Sep 20236:06 pmRNSAmendment to Financial Results announcement
25th Sep 20237:00 amRNSFinancial results for the year ended 30 June 2023
26th Jul 20237:00 amRNSTrading Statement
11th Apr 20237:00 amRNSSAYE and Director/PDMR Shareholding
7th Mar 20235:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.